Wednesday, July 8, 2026
🇺🇸 FDA

biotech · Hematological or solid tumor malignancies or autoimmune diseases · Intracerebral Haemorrhage · IPSC

Century Therapeutics

Century Therapeutics patent portfolio — 39 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
Philadelphia, USA HQ
2018 Founded
104 Employees
Public company Type
IPSC · NYSE Ticker
Company details
Status
Public
HQ
Philadelphia, USA
Founded
2018
Employees
104
Programs
10
Drugs
9
Patents
39
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Century Therapeutics patents

39 pharmaceutical patents indexed for Century Therapeutics. 3 expire within 24 months.

Century Therapeutics has 39 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 3 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

39 patents

Patent portfolio

  1. US 12274710

    Compound for regulating body weight imbalance, composition thereof and application thereof

    Expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12269888

    Artificial cell death polypeptide for chimeric antigen receptor and uses thereof

    Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12194049

    Composition for treating carbapenem antibiotic-resistant Acinetobacter baumannii infection

    Expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12084670

    Regulating alkaloids

    Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11883432

    Chimeric antigen receptor system with adaptable receptor specificity

    Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11865155

    Plant extract obtained from Morus plant leaves which has an IC50 value to inhibit a-glucosidase I at a concentration of less than 90 uG/ml, compositions containing same, method of extraction and uses thereof

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11667924

    Increasing levels of nicotinic alkaloids in plants

    Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11661459

    Artificial cell death polypeptide for chimeric antigen receptor and uses thereof

    Expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11572568

    Regulating alkaloids

    Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11401246

    Triazole glycolate oxidase inhibitors

    Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11236056

    Small molecules and methods of reducing injuries caused by radiation or chemicals

    Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11090349

    Plant extract obtained from Morus plant leaves, compositions containing same, method of extraction and uses thereof

    Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10907170

    Increasing levels of nicotinic alkaloids in plants

    Expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10829774

    Increasing levels of nicotinic alkaloids in plants

    Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10731172

    Regulating alkaloids

    Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10287596

    Regulating alkaloids

    Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10190129

    Increasing levels of nicotinic alkaloids in plants

    Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10076527

    Standardized extract and its use in the manufacture of a medicament

    Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10016474

    Plant extract, compositions containing same, method of extraction and uses thereof

    Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9994860

    Regulating alkaloids

    Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9719103

    Increasing levels of nicotinic alkaloids in plants

    Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9551003

    Increasing levels of nicotinic alkaloids in plants

    Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9283256

    Antibacterial composition comprising Salvia extracts

    Expires Mon Mar 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9126058

    Mouthwash composition

    Expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9102948

    Regulating alkaloids

    Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9056046

    Standardized extract and its use in the manufacture of a medicament

    Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8980343

    Plant extract, compositions containing same, method of extraction and uses thereof

    Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8728447

    Teeth-whitening gel

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8642107

    Water formulation with herbal hint and a process therefor

    Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8530405

    Method of preparing water-soluble and biodegradable antimicrobial agent

    Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8044093

    Pharmaceutical compositions comprising docetaxel and methods for preparation thereof

    Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7691872

    Methods and compositions for optimizing blood and tissue stability of camptothecin and other albumin-binding therapeutic compounds

    Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7662607

    Chalaropsis lysozyme protein and its method of use in anti-bacterial applications

    Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7608268

    Ferritin fusion proteins for use in vaccines and other applications

    Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7253147

    Modified serum albumin with reduced affinity for nickel and copper

    Expires Mon Aug 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7208580

    Atomic structure of the hemalbumin complex and its use in designing therapeutic compounds

    Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7097841

    Ferritin fusion proteins for use in vaccines and other applications

    Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 6949691

    Human albumin animal models for drug evaluation, toxicology and immunogenicity studies

    Expires Mon Sep 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6787636

    Modified serum albumin with reduced affinity for nickel and copper

    Expires Mon Sep 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Century Therapeutics have?

39 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Century Therapeutics patents expire?

3 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.